Title : Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma.

Pub. Date : 2019 May

PMID : 30801908






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma. nz-12 podoplanin Homo sapiens
2 Higher podoplanin expression levels were observed in human mesothelioma specimens, suggesting higher tumor accumulation of 90 Y-labeled NZ-12 in patients compared with the H226 tumor xenografts. nz-12 podoplanin Homo sapiens